Highlights
The global Covid-19 Antibody Test market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Covid-19 Antibody Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Covid-19 Antibody Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Covid-19 Antibody Test in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Covid-19 Antibody Test include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Covid-19 Antibody Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Antibody Test.
The Covid-19 Antibody Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Covid-19 Antibody Test market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Antibody Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Shanghai Xinchao Biology Technology
BGI
Wuhan Easy Diagnosis Biomedicine
Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay
Segment by Application
Hospital
Academic and Research Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Covid-19 Antibody Test companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Covid-19 Antibody Test 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rapid Diagnostic Test (RDT)
1.2.3 Enzyme Linked Immunosorbent Assay (ELISA)
1.2.4 Neutralization Assay
1.3 麻豆原创 by Application
1.3.1 Global Covid-19 Antibody Test 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Academic and Research Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Antibody Test 麻豆原创 Perspective (2018-2029)
2.2 Covid-19 Antibody Test Growth Trends by Region
2.2.1 Global Covid-19 Antibody Test 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Covid-19 Antibody Test Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Covid-19 Antibody Test Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Covid-19 Antibody Test 麻豆原创 Dynamics
2.3.1 Covid-19 Antibody Test Industry Trends
2.3.2 Covid-19 Antibody Test 麻豆原创 Drivers
2.3.3 Covid-19 Antibody Test 麻豆原创 Challenges
2.3.4 Covid-19 Antibody Test 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Antibody Test Players by Revenue
3.1.1 Global Top Covid-19 Antibody Test Players by Revenue (2018-2023)
3.1.2 Global Covid-19 Antibody Test Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Covid-19 Antibody Test 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Antibody Test Revenue
3.4 Global Covid-19 Antibody Test 麻豆原创 Concentration Ratio
3.4.1 Global Covid-19 Antibody Test 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Antibody Test Revenue in 2022
3.5 Covid-19 Antibody Test Key Players Head office and Area Served
3.6 Key Players Covid-19 Antibody Test Product Solution and Service
3.7 Date of Enter into Covid-19 Antibody Test 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Antibody Test Breakdown Data by Type
4.1 Global Covid-19 Antibody Test Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Covid-19 Antibody Test Forecasted 麻豆原创 Size by Type (2024-2029)
5 Covid-19 Antibody Test Breakdown Data by Application
5.1 Global Covid-19 Antibody Test Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Covid-19 Antibody Test Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Covid-19 Antibody Test 麻豆原创 Size (2018-2029)
6.2 North America Covid-19 Antibody Test 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Covid-19 Antibody Test 麻豆原创 Size by Country (2018-2023)
6.4 North America Covid-19 Antibody Test 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Antibody Test 麻豆原创 Size (2018-2029)
7.2 Europe Covid-19 Antibody Test 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Covid-19 Antibody Test 麻豆原创 Size by Country (2018-2023)
7.4 Europe Covid-19 Antibody Test 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Antibody Test 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Covid-19 Antibody Test 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Covid-19 Antibody Test 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Covid-19 Antibody Test 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Antibody Test 麻豆原创 Size (2018-2029)
9.2 Latin America Covid-19 Antibody Test 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Covid-19 Antibody Test 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Covid-19 Antibody Test 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Antibody Test 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Covid-19 Antibody Test 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Covid-19 Antibody Test 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Covid-19 Antibody Test 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Detail
11.1.2 Cellex Business Overview
11.1.3 Cellex Covid-19 Antibody Test Introduction
11.1.4 Cellex Revenue in Covid-19 Antibody Test Business (2018-2023)
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Covid-19 Antibody Test Introduction
11.2.4 Abbott Revenue in Covid-19 Antibody Test Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Covid-19 Antibody Test Introduction
11.3.4 Roche Revenue in Covid-19 Antibody Test Business (2018-2023)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Detail
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics Covid-19 Antibody Test Introduction
11.4.4 BioMedomics Revenue in Covid-19 Antibody Test Business (2018-2023)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Covid-19 Antibody Test Introduction
11.5.4 BD Revenue in Covid-19 Antibody Test Business (2018-2023)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Detail
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein Covid-19 Antibody Test Introduction
11.6.4 Henry Schein Revenue in Covid-19 Antibody Test Business (2018-2023)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Detail
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech Covid-19 Antibody Test Introduction
11.7.4 Safecare Bio-Tech Revenue in Covid-19 Antibody Test Business (2018-2023)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Detail
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories Covid-19 Antibody Test Introduction
11.8.4 Mayo Clinic Laboratories Revenue in Covid-19 Antibody Test Business (2018-2023)
11.8.5 Mayo Clinic Laboratories Recent Development
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Detail
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics Covid-19 Antibody Test Introduction
11.9.4 Chembio Diagnostics Revenue in Covid-19 Antibody Test Business (2018-2023)
11.9.5 Chembio Diagnostics Recent Development
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Detail
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory Covid-19 Antibody Test Introduction
11.10.4 Mount Sinai Laboratory Revenue in Covid-19 Antibody Test Business (2018-2023)
11.10.5 Mount Sinai Laboratory Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics Covid-19 Antibody Test Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in Covid-19 Antibody Test Business (2018-2023)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Detail
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech Covid-19 Antibody Test Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in Covid-19 Antibody Test Business (2018-2023)
11.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Detail
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology Covid-19 Antibody Test Introduction
11.13.4 Innovita Biological Technology Revenue in Covid-19 Antibody Test Business (2018-2023)
11.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Detail
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech Covid-19 Antibody Test Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in Covid-19 Antibody Test Business (2018-2023)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Detail
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific Covid-19 Antibody Test Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in Covid-19 Antibody Test Business (2018-2023)
11.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Detail
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) Covid-19 Antibody Test Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in Covid-19 Antibody Test Business (2018-2023)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
11.17.1 ADVAITE Company Detail
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE Covid-19 Antibody Test Introduction
11.17.4 ADVAITE Revenue in Covid-19 Antibody Test Business (2018-2023)
11.17.5 ADVAITE Recent Development
11.18 Shanghai Xinchao Biology Technology
11.18.1 Shanghai Xinchao Biology Technology Company Detail
11.18.2 Shanghai Xinchao Biology Technology Business Overview
11.18.3 Shanghai Xinchao Biology Technology Covid-19 Antibody Test Introduction
11.18.4 Shanghai Xinchao Biology Technology Revenue in Covid-19 Antibody Test Business (2018-2023)
11.18.5 Shanghai Xinchao Biology Technology Recent Development
11.19 BGI
11.19.1 BGI Company Detail
11.19.2 BGI Business Overview
11.19.3 BGI Covid-19 Antibody Test Introduction
11.19.4 BGI Revenue in Covid-19 Antibody Test Business (2018-2023)
11.19.5 BGI Recent Development
11.20 Wuhan Easy Diagnosis Biomedicine
11.20.1 Wuhan Easy Diagnosis Biomedicine Company Detail
11.20.2 Wuhan Easy Diagnosis Biomedicine Business Overview
11.20.3 Wuhan Easy Diagnosis Biomedicine Covid-19 Antibody Test Introduction
11.20.4 Wuhan Easy Diagnosis Biomedicine Revenue in Covid-19 Antibody Test Business (2018-2023)
11.20.5 Wuhan Easy Diagnosis Biomedicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Shanghai Xinchao Biology Technology
BGI
Wuhan Easy Diagnosis Biomedicine
听
听
*If Applicable.
